Supreme Court Preserves Abortion Pill Access Nationwide

Women seeking medication abortions can breathe easier today after the Supreme Court blocked restrictions that would have upended access to a safe, FDA-approved drug used by millions.

The court's decision Thursday preserves access to mifepristone, allowing women to continue receiving the pill by mail or through telehealth appointments without requiring in-person doctor visits. The drug has been available this way since the FDA removed the in-person requirement five years ago.

Louisiana had sued to roll back these access rules, claiming they undermined the state's abortion ban and questioning the drug's safety. Lower courts sided with the state and ordered mail delivery and telehealth access suspended while the lawsuit played out.

But the Supreme Court stepped in to maintain the status quo. Access will remain uninterrupted at least into 2027 as the case continues through the legal system.

The Bright Side

This marks the second time in three years the Supreme Court has blocked attempts to restrict mifepristone access. In 2024, the court unanimously dismissed a similar lawsuit brought by physicians who opposed abortion, ruling they didn't have legal standing to sue.

The FDA first approved mifepristone for abortion in 2000 and has consistently deemed it safe and effective. Medication abortions using mifepristone and another drug called misoprostol now account for nearly two-thirds of all abortions in the U.S.

Mainstream medical groups, pharmaceutical companies, and health policy experts had urged the court to preserve access. Drug makers warned that restricting an FDA-approved medication based on political objections would "upend the drug approval process" and create uncertainty for all medications.

The decision means women across the country, including those in states with abortion bans, can continue accessing medication through telehealth providers who ship pills from states where abortion remains legal. This pathway has become increasingly important as more than a dozen states have effectively banned abortion procedures since Roe v. Wade was overturned four years ago.

For many women, especially those in rural areas or with limited transportation, telehealth access to mifepristone represents the difference between being able to access reproductive healthcare or not. The ability to receive the medication by mail without traveling long distances or taking time off work removes significant barriers.

Today's ruling ensures that barrier stays removed.